0001968202-24-000090.txt : 20240403 0001968202-24-000090.hdr.sgml : 20240403 20240403160602 ACCESSION NUMBER: 0001968202-24-000090 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240401 FILED AS OF DATE: 20240403 DATE AS OF CHANGE: 20240403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RYAN ARTHUR F CENTRAL INDEX KEY: 0001187443 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 24818704 MAIL ADDRESS: STREET 1: CITIZENS FINANCIAL GROUP, INC STREET 2: 600 WASHINGTON BOULEVARD CITY: STAMFORD STATE: CT ZIP: 06901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2024-04-01 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001187443 RYAN ARTHUR F 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 1 Common Stock 2024-04-01 4 S 0 2 957.78 D 18280 D Common Stock 2024-04-01 4 S 0 2 958.86 D 18278 D Common Stock 2024-04-01 4 S 0 9 959.47 D 18269 D Common Stock 2024-04-01 4 S 0 15 960.53 D 18254 D Common Stock 2024-04-01 4 S 0 14 961.59 D 18240 D Common Stock 2024-04-01 4 S 0 9 962.42 D 18231 D Common Stock 2024-04-01 4 S 0 20 963.6 D 18211 D Common Stock 2024-04-01 4 S 0 16 964.45 D 18195 D Common Stock 2024-04-01 4 S 0 13 965.35 D 18182 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 7, 2023. Represents volume-weighted average price of sales of 9 shares of Company stock on April 1, 2024 at prices ranging from $959.13 to $959.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2024 at each separate price. Represents volume-weighted average price of sales of 15 shares of Company stock on April 1, 2024 at prices ranging from $960.06 to $960.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2024 at each separate price. Represents volume-weighted average price of sales of 14 shares of Company stock on April 1, 2024 at prices ranging from $961.10 to $961.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2024 at each separate price. Represents volume-weighted average price of sales of 9 shares of Company stock on April 1, 2024 at prices ranging from $962.06 to $962.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2024 at each separate price. Represents volume-weighted average price of sales of 20 shares of Company stock on April 1, 2024 at prices ranging from $963.02 to $963.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2024 at each separate price. Represents volume-weighted average price of sales of 16 shares of Company stock on April 1, 2024 at prices ranging from $964.02 to $964.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2024 at each separate price. Represents volume-weighted average price of sales of 13 shares of Company stock on April 1, 2024 at prices ranging from $965.00 to $965.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2024 at each separate price. /s/**Arthur F. Ryan 2024-04-03